Annals of Family Medicine 4:253-262 (2006)
© 2006 Annals of Family Medicine, Inc.
doi: 10.1370/afm.517
Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes
Gerald Gartlehner, MD, MPH1,
Richard A. Hansen, PhD, RPh2,
Shannon S. Carson, MD3 and
Kathleen N. Lohr, PhD4
1 Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC
2 Division of Pharmaceutical Policy and Evaluative Sciences, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC
3 Division of Pulmonary and Critical Care Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
4 Department of Health Policy & Administration, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC


View larger version (38K):
[in a new window]
|
Figure 2. Relative risk meta-analysis of effects of inhaled corticosteroids on exacerbations.
COPD = chronic obstructive pulmonary disease; DPI = dry powder inhaler; MDI = metered dose inhaler.
|
|


View larger version (52K):
[in a new window]
|
Figure 3. Relative risk meta-analysis of effects of inhaled corticosteroids: all-cause mortality.
ICS = inhaled corticosteroid; COPD = chronic obstructive pulmonary disease.
|
|
Copyright © 2006 by the Annals of Family Medicine.